Back
ESC Premium Access

Characterization of major and clinically relevant non-major bleeding in the APEX trial

Session: Oral anticoagulants : news from large trials and registries
Topic: Anticoagulants
Speaker: Miss M. Yee (Boston, US)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Miss Megan Yee

Boston (United States of America)
0 follower

5 more presentations in this session

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Speaker: Doctor R. Amiya (Osaka, JP)

Access
Abstract
Slides
Like
Thumbnail

Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)

Access
Abstract
Slides
Like
Thumbnail

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Speaker: Professor H. Jeong (Iksan, KR)

Access
Abstract
Slides
Like
Thumbnail

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Speaker: Mr J. Strange (Copenhagen, DK)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Oral anticoagulants : news from large trials and registries

Speakers: Miss M. Yee, Doctor R. Amiya, Doctor M. Lamberts, Doctor M. Proietti, Professor H. Jeong...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources